HealthTree Logo
search more_vert
person Sign In / Create Account
Using the Newly Approved Isatuximab in the Myeloma Clinic with Tom Martin, MD, USCF
Using the Newly Approved Isatuximab in the Myeloma Clinic with Tom Martin, MD, USCF image
HealthTree Podcast for Multiple Myeloma
event Jun 05, 2020 / 11:00AM MDT

Event Description

Thomas Martin, MD
University of California at San Francisco
Interview Date: June 5, 2020

New treatment options are availalble for myeloma patients including a newly approved monoclonal antibody called isatuximab (Sarclisa). Learn from Dr. Tom Martin about this new option and how it works differently from other CD targeted monoclonal antibodies used today. He shares how isatuximab is administered, how it is being combined in further clinical trials, when it might be considered and more. Interestingly, Dr. Martin shares that isatuximab can be considered after the use of daratumumab (or visa versa) if the use is separated by a different line of therapy that allows the CD38 expression to re-appear. Learn more about this important new tool in the myeloma toolbox. 

Thanks to our episode sponsor

Bristol Myers-Squibb

Schedule & Agenda

Dr. Tom Martin & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube